J Korean Orthop Assoc. 2008 Aug;43(4):479-487. Korean.
Published online Aug 31, 2008.
Copyright © 2008 The Korean Orthopaedic Association
Original Article

HIF-1α and VEGF Expression in Fracture Healing

Jung-Jae Kim, M.D., Hyun-Chul Shon, M.D.,* Jae-Suk Chang, M.D., Jung-Hwa Kim, Kang-Sik Lee and Seok-Won Kim, M.D.*
    • Department of Orthopedic Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.
    • *Department of Orthopedic Surgery, Chungbuk National University College of Medicine, Cheongju, Korea.

Abstract

Purpose

To elucidate the relation between fracture healing and angiogenesis, we checked expression of Hypoxia-inducible factor (HIF) and Vascular endothelial growth factor (VEGF) in hypoxic cell cultures and the callus from a rat femur fracture model.

Materials and Methods

Human osteoblasts, chondrocytes, and rat ST2 cells were cultured in DME/F12 media with 10% FBS. Hypoxic DME/F12 media (PO2<60 mmHg) was generated by bubbling with 95% N2 and 5% CO2 and added to cells. After 2, 6, and 24 hours, RNA and proteins were collected for reverse transcription - polymerase chain reaction (RT-PCR) and Western blot. In addition, immunocytochemistry and siRNA treatment for HIF-1α were performed. Next, femurs from 9-week SD rats were fractured after fixation with needles. The rats were sacrificed at post-fracture day (PFD) 3, 5, 7, 10, 14, 21 and calluses were collected for RT-PCR and Western blot.

Results

HIF-1α and HIF-2α expression were not increased in RT-PCR but protein levels were increased. VEGF expression in RT-PCR was increased. Treatment with siRNA directed towards HIF inhibited VEGF expression. In the rat fracture callus, HIF-1α and VEGF expression peaked between PFD 5 and 7 and decreased after PFD 10. In contrast to cell culture, mRNA expression of HIF-1α was increased at PFD 7.

Conclusion

HIF-1α and VEGF peaked early in fracture healing. With expression decreasing as O2 tension increased. Further study is needed to identify other factors affecting chondrogenic differentiation.

Keywords
HIF-1α; VEGF; Fracture healing

Figures

Fig. 1
Hypoxia does not induce HIF-1α mRNA expression (A, B) but increases protein levels (C, D). N, normoxia; H, hypoxia.

Fig. 2
Hypoxia does not induce HIF-2α mRNA expression (A, B) but increases protein levels (C, D).

Fig. 3
Hypoxia increases VEGF mRNA expression in ST2 cells (A) and chondrocytes (B).

Fig. 4
Hypoxia does not induce HIF-1α and HIF-2α mRNA expression but increases protein levels. HIF-1α, HIF-2α and VEGF expression in human osteoblasts shows similar expression patterns to ST2 cells and chondrocytes.

Fig. 5
Human chondrocyte immunocytochemistry shows increased expression of HIF and VEGF in hypoxia.

Fig. 6
VEGF expression was decreased by treatment with siRNA for HIF-1α in human osteoblasts. Mock, transfection control.

Fig. 7
VEGF expression was decreased by treatment with siRNA for HIF-1α in human chondrocytes. Mock, transfection control.

Fig. 8
Western blot for HIF-1α in callus shows elevation at early stages of fracture healing (peak at PFD 5) and decreases after PFD 10.

Fig. 9
RT-PCR for HIF-1α in callus shows elevation at early stages of fracture healing (peak at PFD 7).

Fig. 10
RT-PCR for VEGF in callus shows elevation at early stages of fracture healing (peak at PFD 5) and decreases after PFD 10.

References

    1. Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol 1954;38:397–432.
    1. Brighton CT, Hunt RM. Early histological and ultrastructural changes in medullary fracture callus. J Bone Joint Surg Am 1991;73:832–847.
    1. Choi P, Ogilvie C, Thompson Z, Miclau T, Helms JA. Cellular and molecular characterization of murine non-union model. J Orthop Res 2004;22:1100–1101.
    1. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275–288.
    1. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcripthion by hypoxia-inducible factor 1. Mol Cell Biol 1996;16:4604–4613.
    1. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003;88:873–884.
    1. Gleadle JM, Ebert BL, Firth J, Ratcliffe PJ. Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am J Physiol 1995;268:C1362–C1368.
    1. Goldberg MA, Schneider TJ. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin . J Biol Chem 1994;269:4355–4359.
    1. Grundnes A, Reikerås O. The importance of the hematoma for fracture healing in rats. Acta Orthop Scand 1993;64:340–342.
    1. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001;292:468–472.
    1. Jelkmann W. Erythropoitin: structure, control of production, and function. Physiol Rev 1992;72:449–489.
    1. Komatsu DE, Hadjiargyrou M. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone 2004;34:680–688.
    1. Kourembanas S, Hannan RL, Faller DV. Oxygen tension regulates the expression of the platelet-derived growth factor-β chain gene in human endothelial cells. J Clin Invest 1990;86:670–674.
    1. Krishnamachary B, Berg-Dixon S, Kelly B, et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003;63:1138–1143.
    1. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducuble factor. Genes Dev 2002;16:1466–1471.
    1. Lee JW, Bae SH, Jeong JW, Kim SH, Lim KW. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Exp Mol Med 2004;36:1–12.
    1. Marsh D. Concepts of fracure union, delayd union, and nonunion. Clin Orthop Relat Res 1998;355 Suppl 355:S22–S30.
    1. Mizuno K, Mieno K, Tachibana T, Sumi M, Hirohata K. The osteogenetic potential of fracture haematoma. Subperiosteal and intramuscular transplantation of the haematoma. J Bone Joing Surg Br 1990;72:822–829.
    1. Pufe T, Wildemann B, Petersen W, Mentlein R, Raschke M, Schmidmaier G. Quantitative measurement of the spilce variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res 2002;309:382–392.
    1. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003;9:677–684.
    1. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843–845.
    1. Street J, Bao M, deGuzman L, et al. Vascular endothelial growth fator stimulates bone repair by promoting angiogenesis and bone turnover. Proc natl Acad Sci USA 2002;99:9656–9661.
    1. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 1955;9:539–549.
    1. Uchida S, SAkai A, Kudo H, et al. Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 2003;32:491–501.
    1. Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J 2002;16:1151–1162.

Metrics
Share
Figures

1 / 10

PERMALINK